American Journal of Hematology · 1985 · 17 citations · 13 references
MedicineHematologyInternal MedicineClinical BiochemistryHemostasisTransfusion MedicineCoagulation AbnormalitiesCoagulation DisordersHemostatic DisordersPlatelet FunctionPlatelet TransfusionThrombosisActivated Partial Thromboplastin Time ProlongationFactor V PhysiologyHemorrhagic ManifestationsPlatelet Transfusion TherapyProthrombin ActivationProthrombin Complex Concentrate UseThrombosis MechanismsTransfusion In Coagulopathy
A 57-year-old married Chinese male without a family history of bleeding disorder was presented with severe hemorrhagic tendency and was subsequently found to be suffering from an acquired inhibitor against coagulation factor V. The prolonged prothrombin time and activated partial thromboplastin time could not be corrected by the addition of normal plasma. Subnormal value of factor V level was noted accompanied with an abnormal platelet factor III availability test. With specific antisera and staphylococcal protein A, the inhibitor was characterized as an IgG(lambda) antibody. The hemorrhagic tendency and abnormal laboratory data were corrected after treating the patient with platelet concentrate transfusion and cyclophosphamide.
13
Human Blood Coagulation, Haemostasis and Thrombosis
G. I. C. Ingram · Journal of Clinical Pathology · 1977 · 228 citations · Full text
Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions
Juan Chediak, J Ashenhurst, I Garlick et al. · Blood · 1980 · 111 citations · Full text
Factor V Antibody and Disseminated Intravascular Coagulation
Thomas A. Lane · Annals of Internal Medicine · 1978 · 30 citations
Medicine, Immunology, Pathology +11